Fertility Test Market to Develop Rapidly by 2022-2031

The global fertility test market was valued at USD 472 million in 2021 and it is anticipated to grow further up to USD 979.9 million by 2031, at a CAGR of 7.6% during the forecast period.

New York, According to a new market research report published by Global Insight Services “Fertility Test Market” is expected to reach US$ XX bn by 2031. Report includes in-depth segmentation and market size data by categories, product types, applications, and geographies. Report also includes comprehensive analysis of key issues, trends and drivers, restraints and challenges, competitive landscape, as well as recent events such as M&A activities in the market.

A medical and physical assessment called a fertility test measures a person’s capacity to conceive naturally. Growing older is one of the factors that might impair fertility, therefore women and men who are 35 or older who are having trouble becoming pregnant even after six months of trying should think about fertility testing. Blood tests, discussions of medical history, and minimally invasive procedures are all part of the fertility testing procedure. It mostly includes detecting hormones like luteinizing hormone or progesterone hormone in blood, urine, or saliva to determine whether ovulation has occurred. Semen analysis is part of the tests for males to ensure a proper sperm count.

Download Sample of Report :

Market Trends and Drivers

The increasing first-time pregnancy age is propelling the growth of the market. Due to the drop in first pregnancies among teenage girls and the rise in pregnancies among women over 30, the average age of first pregnancies has dramatically increased globally during the past few decades. The average age at which women give birth is now 30 or older, according to the OECD; this development is primarily being noticed since women over the world are showing a higher preference for delaying first pregnancies. Listed below are some significant products launched in recent years:

  • The average mean age of a first pregnancy in the OECD-25 nations climbed from 29 to 30 between 2015 and 2019 according to the OECD Family Database. The only OECD nation with a mean average age of 28 or less is Mexico.
  • Only 11.8 births per 1,000 young women (under the age of 20) have their first child, which is in line with the rising mean age of first-time pregnancies (Source: OECD).
  • UNICEF reports that between 2005 and 2017, the average age of Canadian women giving birth to their first child rose by 1.5 years, from 27.5 to 29.
  • The average age of first-time moms in the Netherlands grew from 29.4 years in 2013 to 29.9 years in 2019. (Source: CBS, 2019).
Market Restraints and Challenges

The lesser precision of ovulation prediction kits is anticipated to hinder the growth of the market during the forecast period. The luteinizing hormone (LH) spike that occurs 24-36 hours before ovulation is measured by ovulation prediction kits. However, ovulation cannot be precisely confirmed using these kits. Ovulation predictors are not reliable in cases like luteinized unruptured follicle syndrome, which happens when a woman’s egg does not break free from her follicle after the LH surge. Additionally, urinary LH measurement only predicts the beginning of ovulation and cannot pinpoint the day of ovulation or anovulation, indicating a very brief window of opportunity for conception.

Only LH can be detected by ovulation monitors; they are unable to detect other crucial ovulation indicators, such as if the cervical mucous is conducive to fertilization. Additionally, these monitors are ineffective in the presence of the hormone hCG (Human Chorionic Gonadotropin) or some fertility medications like Personal in the urine. The fact that these kits do not work for women in their 40s (particularly those who are close to menopause) due to elevated levels of LH is another significant disadvantage. These drawbacks of ovulation monitors reduce their predictive power, which is preventing end users from using them.

Purchase your copy now :

Global Fertility Test Market Segmentation

By Product

Ovulation Prediction Kits
Fertility Monitors
Male Fertility Test Kits

By Mode of Purchase

Prescription Based

Major Players in the Global Fertility Test Market

The key players studied in the global fertility test market are Swiss Precision Diagnostics (Switzerland), Church & Dwight (US), Prestige Brands Holdings (US), bioZhena (US), Fairhaven Health (US), Fertility Focus (UK), Geratherm Medical (Germany), Hilin Life Products (US), UEBE Medical (Germany),  AdvaCare Pharma (US),  AVA (Switzerland), Babystart (UK), Valley Electronics (Germany)and Mira Care (US).

Get A Customized Scope to Match Your Need Ask an Expert :

Reasons to buy Fertility Test Market Report:

• Develop comprehensive understanding of market landscape – industry structure, value-chain, key players, trends, drivers, and challenges
• Drive revenue and market-entry strategy by gaining insights into which segments and geographies are largest and likely to grow fastest
• Formulate sales and marketing strategies by gaining understanding of competitors, their positioning, and strengths & weaknesses
• Develop business and M&A strategies through understanding of latest trends and emerging players in the market
• Refine your business plans by understanding impact of disruptions such as Covid-19 and Russia-Ukraine conflict on the market

About Global Insight Services:

Global Insight Services (GIS) is a leading multi-industry market research firm headquartered in Delaware, US. We are committed to providing our clients with highest quality data, analysis, and tools to meet all their market research needs. With GIS, you can be assured of the quality of the deliverables, robust & transparent research methodology, and superior service.

Contact Us:

Global Insight Services LLC
16192, Coastal Highway, Lewes DE 19958
Phone: +1-833-761-1700